October is known for above-average volatility, though the reasons are unclear. Expect more of the same this time around.
VIDEO ON MSN MONEY
Russians are now paying more at the supermarket for poultry products while American producers remain largely unscathed.
Putin's move in early August to block American chickens has backfired, sources in the poultry industry say, leaving Russians to pay more at the supermarket for poultry products while American producers remain largely unscathed.
The Kremlin put agricultural sanctions in place against several Western nations in retaliation for penalties from the U.S. and European Union following Russia's invasion of Ukraine.
"The real loser is the average Russian consumer, who is now faced with less choices and increased prices for poultry," said Tom Super, a spokesman for the National Chicken Council. Poultry prices in Russia have risen about 2-3 percent each week since the ban, according to Super.
This group is backed by fabulous science and strong performance, and reminds us of our nation's innovative spirit.
Biotech is so fluid, so exciting, and so phenomenal in this county. In what can only be described as a gloomy moment in the U.S. and the world, I tend to take solace in what is happening in this amazing group as a reminder of our nation's innovative spirit and fabulous science.
Let's take Celgene (CELG), which has long been my big capitalization favorite in the group -- except when Regeneron (REGN) announces another breakthrough in eye care or the battle against cholesterol where there's plenty of news today that's powering the stock higher.
When I wrote my latest book, "Get Rich Carefully," I praised the group embracing the Four Horsemen of Biotech, namely Biogen Idec (BIIB), Celgene, Gilead (GILD) and Regeneron, a quartet I am proud to say has performed astoundingly well. They were led by Gilead because of its miraculous pill that cures Hepatitis C, which is a potentially fatal disease. That stock is up 42 percent.
Investors can learn a lot about the financial sector by taking a look at his approach.
For a man who has been known to say some uncomplimentary things about bankers, Warren Buffett sure does love his bank stocks.
By one recent analysis, the "big banks" and regional banks that Berkshire Hathaway (BRK.A) has amassed in its portfolio of stocks adds up to a $50 billion market cap banking company -- four of Berkshire Hathaway's top 11 holdings in the stock market are in banks and other financial services companies.
For a little perspective, the combined market value of Buffett's bank stock holdings roughly equals the market cap of Deutsche Bank (DB) or PNC Financial (PNC) and would rank eighth overall in terms of U.S. banks by size. That $50 billion banking "company" stocked away within Buffett's empire is also a sizable piece of Berkshire Hathaway's approximately $350 billion valuation.
The company reports its latest quarter Thursday, and analysts are bullish after seeing favorable pricing trends.
As Nike's (NKE) shares trade near an all-time high, investors are asking ahead of its fiscal first-quarter earnings on Thursday whether the Dow member is still a buy.
The answer looks to be a resounding yes, judging by the 70 percent of 30 analysts polled by FactSet with a bullish rating. That's the highest percentage since at least 2012, when only about two-fifths on Wall Street were recommending the stock.
Why all the excitement?
The market surges Wednesday, fueled by investor expectations that relief for commodities could be on the way.
By Anthony Mirhaydari
Stocks surged Wednesday to end a three-day losing streak, posting the best single-session gain since the middle of August. The bulls waited as long as they could, rushing in to defend the Standard & Poor's 500 Index's ($INX) 50-day moving average.
This came after they watched in horror earlier this week as ongoing weakness in small-cap stocks pushed the Russell 2000 ($TOMX) down through a "death cross" for the first time since 2011 -- a result of the 50-day moving average dropping below the 200-day moving average.
The catalyst was, along with some good housing data here at home, the specter of more cheap money stimulus. It's been the dominant theme of the market over the last few years. And it played its role yet again on headlines out of China that got investors excited that the Middle Kingdom -- which has seen shares drop in response to disappointing economic data -- was about to reopen the flood gates of liquidity.
Bionym's device features sensors that capture a user's unique cardiac rhythm.
A tech start-up that wants to replace passwords with heartbeats just got some major backing.
Bionym, a Toronto-based company that develops authentication technology, announced Wednesday it has closed a $14 million Series A round of funding, led by venture capital firms Ignition Partners and Relay Ventures. Mastercard (MA), Salesforce Ventures and Export Development Canada are also investors.
Bionym's wristband (pictured), which is called the Nymi, uses a wearer's heartbeat to unlock devices and online accounts. The $79 device is slated to debut this fall and already has more than 10,000 preorders.
The Passport costs $599 without a contract and has an unusual square-shaped screen.
Many critics will make the mistake of comparing its prospects to Apple's (AAPL) iPhone 6 and 6 Plus, but it's not competing in the same arena.
Put another way, BlackBerry Passport will be a breathtaking success if it sells as many phones in six months as the 10 million that Apple sold last weekend.
Under CEO John Chen (pictured), BlackBerry has staked its future on becoming a provider of secure enterprise software. Apple is selling phones while BlackBerry is using phones to market its focus on the secure enterprise.
Sam Waksal is barred from serving as an officer of a public company, so his brother will take the reins.
Sam Waksal (pictured) is ready for Act II.
The details of the scientist-turned-CEO's first act are well known: founding ImClone, the maker of the cancer drug Erbitux, then insider trading charges and a five-year prison term -- a scandal that also brought jail time for his friend Martha Stewart.
Waksal emerged from prison in 2009, the year after ImClone was sold to Eli Lilly (LLY) for $6.5 billion. He's since raised $500 million in debt and equity and founded a new drug company, Kadmon, a closely held firm he's led as chairman and CEO.
As part of his sentence, Waksal was barred permanently by the Securities and Exchange Commission from serving as an officer or director of any public company.
The more interesting question, actually, might be what happens to the market 6 months before rate hikes begin.
Last week the Federal Open Market Committee surprised a lot of pundits by doing what it has said it would do.
The FOMC announced a further reduction of its extraordinary bond buying program -- quantitative easing, or QE3 -- in which the central bank adds liquidity by purchasing Treasuries and mortgage-backed securities.
In September, the Federal Reserve will buy only $15 billion in government-linked securities, down from $85 billion a month late last year, and will likely end QE in October. That's been baked in the cake for some time.
What surprised some people, but really shouldn't have, was the FOMC’s declaration it would keep rates low for a "considerable time" after the central bank ends QE.
Geopolitical risks are clearly rising, yet stocks have not fallen far from their record highs.
By Yuval Rosenberg, The Fiscal Times
Airstrikes in Syria, warnings of an ISIS attack at home, ongoing tensions with Russia: Geopolitical risks have clearly been rising, yet the stock market has not fallen far from its record highs.
Yes, the Standard & Poor's 500 Index ($INX) had its worst day since early August on Monday and continued its slide for a third straight session on Tuesday. But the weakness may have been caused by concerns about economic growth in China and Europe as much as by worries about the Middle East.
Volatility has picked up, but none of the major indexes have suffered large cumulative losses over the last month, with the Dow Jones Industrial Average ($INDU) up slightly, while the S&P 500 and the Nasdaq Composite Index ($COMPX) are down a fraction of a percentage point. Oil futures are near multi-year lows below $100 a barrel.
The small but growing 'Bendgate' controversy appears to involve only the larger version of the phone.
Social media and technology blogs were awash with news on Apple's (AAPL) new iPhone 6 Plus late Tuesday, claiming the new device was suffering from a surprisingly flexible defect.
The claims suggested that the "phablet" -- launched by the Cupertino-based company this month -- is bending in some users pockets, particularly if they are wearing tight jeans.
Online technology show Unbox Therapy went one step further and actually tried to physically bend the product and break it in half. The video has now been watched over 5 million times in just 24 hours.
Apple representatives weren't immediately available for comment when CNBC tried to contact both offices in London and California.
For certain mineral and mining shares, many 20% pullbacks are occurring now and there's no end in sight.
If you didn't know any better, you would say the recession started last week, when the Federal Reserve signaled that the time to get tough is nearing.
The only stocks that reacted well Tuesday were stocks that are staples, which are beneficiaries of the decline in inflation. Everything else, particularly anything that needs even a remotely robust environment to make money, was killed. It was as if the recession chimes went off and people fled from stocks that six months ago they couldn't get enough of.
The industrials acted with violence. And don't I know it. We have some really horribly acting stocks for Action Alerts Plus that are meant to shine in a 3 percent growth environment, and they were crushed. It was the worst day in ages for that kind of portfolio, and the pain is palpable.
EBay's payments unit says it will accept the cryptocurrency for digital goods, such as online games and song downloads.
PayPal and its parent company eBay (EBAY) are warming up to Bitcoin, but they're doing it oh so carefully.
On Tuesday, PayPal announced that it was partnering with Bitcoin processors BitPay, Coinbase and GoCoin to allow its merchants to accept the cryptocurrency for digital goods like online games and downloadable songs.
It's a second baby step for the payments giant toward full Bitcoin adoption after the company's Braintree unit, a mobile payments provider, said earlier this month that it was working on a feature that would let customers of businesses like Uber and Airbnb pay with Bitcoin.
A light news day combined with heavy technicals weighed on the market.
By Anthony Mirhaydari
It was another nasty day for the market, with the major averages slammed into the closing bell to finish on the lows as the correction entered the third day.
Small caps led the way down, with the Russell 2000 down 7.5 percent from its July highs and down 3 percent for the year-to-date.
The Russell 2000 also recently suffered the indignity of a "death cross" -- when its 50-day moving average dropped below its 200-day average for the first time since 2011. While not a great market timing signal, it's indicative of just how serious the selling pressure has become.
That's news to most investors, given that the percentage of bearish respondents to sentiment surveys had recently dropped to levels not seen since 1987 as the Dow Jones Industrial Average and the S&P 500 have both been flirting with record highs.
Bill Stiritz owns more than 5% of the company, and has experienced an estimated $145 million in paper losses on his investment.
Herbalife's (HLF) largest individual shareholder is in the red.
On Monday, shares of Herbalife tanked into Monday's close.
The stock fell 10.31 percent to end the day at $40.21 per share on a false rumor that Carl Icahn was unwinding his position. The stock was last up about 7 percent on Tuesday.
Herbalife is a multilevel marketing firm that sells nutrition products like weight-loss shakes and vitamins. The company has been at the center of a huge hedge fund war for nearly 20 months.
MORE ON MSN MONEY
Copyright © 2014 Microsoft. All rights reserved.
Fundamental company data and historical chart data provided by Morningstar Inc. Real-time index quotes and delayed quotes supplied by Morningstar Inc. Quotes delayed by up to 15 minutes, except where indicated otherwise. Fund summary, fund performance and dividend data provided by Morningstar Inc. Analyst recommendations provided by Zacks Investment Research. StockScouter data provided by Verus Analytics. IPO data provided by Hoover's Inc. Index membership data provided by Morningstar Inc.
US markets were able to rally hard and largely trim the day's losses. Meanwhile, a bounce in crude oil could be in the offing.
Top Stocks provides analysis about the most noteworthy stocks in the market each day, combining some of the best content from around the MSN Money site and the rest of the Web.
Contributors include professional investors and journalists affiliated with MSN Money.
Follow us on Twitter @topstocksmsn.
[BRIEFING.COM] The stock market began the new week on a cautious note. The S&P 500 lost 0.3%, but managed to erase more than half of its opening decline. Thanks to the rebound, the benchmark index reclaimed its 50-day moving average (1976.78) after slipping below that level in the morning.
Equities slumped at the open amid a couple global developments that dampened the overall risk appetite. Continued student protests in Hong Kong and a potential response from China weighed on the ... More
More Market News
|There’s a problem getting this information right now. Please try again later.|